Impact of deployment of artificial intelligence in joint-stock companies' board of directors on legal liability
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
In 2014, a Hong Kong based venture capital firm, active in the field of regenerative medicine, announced that it had appointed an algorithm named VITAL to its board of directors. The announcement accelerated the discussion in academia regarding the deployment of artificial intelligence systems in companies' board of directors. As a matter of fact, rapid developments in the field of artificial intelligence have shown their impact on business models, and just like VITAL, in practice, artificial intelligence systems have started playing an important role in the management of companies. In this regard, the present thesis mainly examines the impact of deployment of artificial intelligence in board of directors of joint stock companies as assisted artificial intelligence, augmented artificial intelligence and autonomous artificial intelligence on the board members' legal liability, within the scope of the commercial law.
Author
Zeynep Dönmez Canseven
How to Cite
Zeynep Dönmez Canseven (Master Thesis). Impact of deployment of artificial intelligence in joint-stock companies' board of directors on legal liability, 2021, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)